Following positive Phase IIb TACTI-003 data, the FDA has endorsed further evaluation of Immutep’s efti-Keytruda combination in first-line recurrent/metastatic HNSCC patients with PD-L1 CPS <1, a ...

Eftilagimod alfa shows promise as a novel immunotherapy for head and neck cancer patients with low PD-L1 expression, offering ...

The US Department of Health and Human Services has terminated 22 mRNA vaccine research contracts under BARDA, signaling a ...

Former FDA Director David Feigal joins Keyron as Head of Regulatory Affairs Dr Joyce Peetermans (ex-Boston Scientific) joins as Acting CTO Christopher Rowland (ex-Boston Scientific) ...

Two men died after a sedan they were traveling in was hit by rocks on a county road in Miaoli County yesterday, the local ...

(Nasdaq: SDGR) today announced financial results for the quarter ended June 30, 2025. "In a highly dynamic macroenvironment, ...

Novo Nordisk CFO Karsten Munk Knudsen tells Yahoo Finance the company understands the pressure it is under to deliver better ...

Secretary Robert F. Kennedy Jr.’s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding will ...

Wednesday marks the 60th anniversary of the landmark legislation becoming law. Those at the epicenter of the fight for voting ...

Keyron announced today that it made significant personnel appointments as it prepares for clinical trials for its ForePass ...

Overall, the initial steps of the wind-down will result the in the cancellation of nearly $500 million. Not all mRNA related ...

The NFL clarified a memo sent to clubs on Tuesday, saying players will still be able to whiff smelling salts during games ...